CEFTRIAXONE INJECTION, USP

baxter corporation🇨🇦 Health Canada

Approval Id: 93a1b9531b73f327
Drug Approval Canada Name: CEFTRIAXONE INJECTION, USP
Product Name: CEFTRIAXONE INJECTION, USP
Status: Marketed
Status Date: 2021-03-18
Original Market Date: 2021-03-18
Din: 02499711
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 08:12.06.12
Atc Original: J01DD04 CEFTRIAXONE
Atc Name: j 01 dd 04
Aig Number: 0117292011
Company Name: baxter corporation
Company Address: 7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2

CEFTRIAXONE (CEFTRIAXONE SODIUM)

1000 MG / 50 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

93a1b9531b73f327

Type

Standard